UNSPSC 51293801: Pirolazamide

This classification denotes an antidepressant agent with the molecular formula C23H29N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GQN5BVM24W, chemically known as pyrrolo(1,2-a)pyrazine-2(1h)-butanamide, hexahydro-alpha,alpha-diphenyl- but generally known as pirolazamide, which bears US NIH Compound Identifier 71442. European Medicines Agency schedules Pirolazamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09933MIG.

UNSPSC 51293801 Pirolazamide, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The single recent opportunity — Seminole County, Florida's IFB for naloxone and drug deactivation systems — involves pharmaceutical products and harm-reduction equipment unrelated to pirolazamide, a veterinary antimicrobial compound. The mismatch suggests a coding classification error in the sourced opportunity rather than meaningful procurement activity under this code's stated scope. State and local buyers do not appear to be actively soliciting pirolazamide through public contracting mechanisms at present.

No additional state and local opportunities for pirolazamide are present in recent records. If your firm has a pirolazamide offering, verify the correct UNSPSC classification with customer procurement offices before pursuing; the current tagging creates visibility noise rather than qualified leads. The Seminole County opportunity, while indexed under this code, represents a distinct procurement family (naloxone and drug deactivation systems) and should not be treated as a precedent for pirolazamide demand in state and local markets.